Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Arthritis Rheumatol. 2014 Nov;66(11):3151–3159. doi: 10.1002/art.38788

Figure 1. Outcomes of patients initially randomized to RTX receiving RTX for severe disease relapse.

Figure 1

Remission – BVAS/WG = 0

Complete response – BVAS/WG = 0 and prednisone ≤ 10mg per day

Complete remission – BVAS/WG = 0 and prednisone = 0mg per day

*Missing data denotes patients who did not have a 12 month visit but continued to be followed in the study until the common close out date.